SUZEPTRO Trademark

Trademark Overview

On Tuesday, July 19, 2016, a trademark application was filed for SUZEPTRO with the United States Patent and Trademark Office. The USPTO has given the SUZEPTRO trademark a serial number of 79193348. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 29, 2023. This trademark is owned by CROSSJECT. The SUZEPTRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical preparations containing sumatriptan for treating migraine and histamine cephalgia only
suzeptro

General Information

Serial Number79193348
Word MarkSUZEPTRO
Filing DateTuesday, July 19, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 29, 2023
Registration Number5220414
Registration DateTuesday, June 13, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceutical preparations containing sumatriptan for treating migraine and histamine cephalgia only

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCROSSJECT
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameCROSSJECT
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameCROSSJECT
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Saturday, October 29, 2016ASSIGNED TO EXAMINER
Friday, November 18, 2016REFUSAL PROCESSED BY IB
Thursday, October 6, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, October 13, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, October 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 18, 2016APPLICATION FILING RECEIPT MAILED
Monday, October 31, 2016NON-FINAL ACTION WRITTEN
Tuesday, November 1, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 2, 2016REFUSAL PROCESSED BY MPU
Wednesday, November 2, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 10, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 8, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 8, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, March 25, 2017NOTIFICATION PROCESSED BY IB
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, September 13, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, September 18, 2017FINAL DISPOSITION NOTICE SENT TO IB
Monday, June 13, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 29, 2023CANCELLED SECTION 71
Friday, August 30, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, September 9, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, September 9, 2024INVALIDATION PROCESSED
Sunday, September 29, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, January 24, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 8, 2017ASSIGNED TO LIE
Friday, February 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 18, 2017FINAL DISPOSITION PROCESSED

Related Keywords

suzeptro pharmaceutical migraine histamine cephalgia only treating sumatriptan products namely preparations